BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35154007)

  • 1. Hyperprolactinemia and Hypopituitarism in Acromegaly and Effect of Pituitary Surgery: Long-Term Follow-up on 529 Patients.
    Guo X; Zhang R; Zhang D; Wang Z; Gao L; Yao Y; Deng K; Bao X; Feng M; Xu Z; Yang Y; Lian W; Wang R; Ma W; Xing B
    Front Endocrinol (Lausanne); 2021; 12():807054. PubMed ID: 35154007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axis-specific analysis and predictors of endocrine recovery and deficits for non-functioning pituitary adenomas undergoing endoscopic transsphenoidal surgery.
    Hwang JY; Aum DJ; Chicoine MR; Dacey RG; Osbun JW; Rich KM; Zipfel GJ; Klatt-Cromwell CN; McJunkin JL; Pipkorn P; Schneider JS; Silverstein JM; Kim AH
    Pituitary; 2020 Aug; 23(4):389-399. PubMed ID: 32388803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Ki-67 in acromegalic patients with hyperprolactinemia: retrospective analysis in 61 Chinese Patients.
    Huan C; Cui G; Lu C; Qu X; Han T
    Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):719-23. PubMed ID: 25796164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.
    Sumislawski P; Huckhagel T; Krajewski KL; Aberle J; Saeger W; Flitsch J; Rotermund R
    Sci Rep; 2023 Feb; 13(1):2468. PubMed ID: 36774403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
    Jahangiri A; Wagner JR; Han SW; Tran MT; Miller LM; Chen R; Tom MW; Ostling LR; Kunwar S; Blevins L; Aghi MK
    J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
    Taweesomboonyat C; Oearsakul T
    World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
    Huan C; Cui G; Ren Z
    Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases.
    Chen M; Duan L; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
    Pituitary; 2023 Dec; 26(6):675-685. PubMed ID: 37847430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
    Nishioka H; Fukuhara N; Horiguchi K; Yamada S
    J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas].
    Fonseca AL; Chimelli L; Santos MJ; Santos AA; Violante AH
    Arq Neuropsiquiatr; 2002 Sep; 60(3-A):590-602. PubMed ID: 12244397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of adrenal insufficiency after transsphenoidal surgery in patients with acromegaly: a long-term follow-up study.
    Burgers AM; Kokshoorn NE; Pereira AM; Roelfsema F; Smit JW; Biermasz NR; Romijn JA
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1163-70. PubMed ID: 21470989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.
    Cheng S; Al-Agha R; Araujo PB; Serri O; L Asa S; Ezzat S
    PLoS One; 2013; 8(9):e73543. PubMed ID: 24039977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up.
    Lv L; Jiang Y; Yin S; Hu Y; Chen C; Ma W; Jiang S; Zhou P
    Endocrine; 2019 Nov; 66(2):310-318. PubMed ID: 31368083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrasellar Pressure is Related to Endocrine Disturbances in Patients with Pituitary Tumors.
    Simander G; Dahlqvist P; Oja L; Eriksson PO; Lindvall P; Koskinen LD
    World Neurosurg; 2023 Jul; 175():e344-e351. PubMed ID: 36966914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term control of acromegaly after pituitary surgery in South-Eastern Norway.
    Falch CM; Dupont AK; Olarescu NC; Wiedmann M; Dahlberg D; Bollerslev J; Berg-Johnsen J; Heck A
    Acta Neurochir (Wien); 2023 Oct; 165(10):3003-3010. PubMed ID: 37665404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
    Almeida JP; Ruiz-TreviƱo AS; Liang B; Omay SB; Shetty SR; Chen YN; Anand VK; Grover K; Christos P; Schwartz TH
    J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery rate of adrenal function after surgery in patients with acromegaly is higher than in those with non-functioning pituitary tumors: a large single center study.
    Yedinak C; Hameed N; Gassner M; Brzana J; McCartney S; Fleseriu M
    Pituitary; 2015 Oct; 18(5):701-9. PubMed ID: 25673267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for Pretreatment Endocrine Evaluation of Patients With Nonfunctioning Pituitary Adenomas.
    Fleseriu M; Bodach ME; Tumialan LM; Bonert V; Oyesiku NM; Patil CG; Litvack Z; Aghi MK; Zada G
    Neurosurgery; 2016 Oct; 79(4):E527-9. PubMed ID: 27635959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.